Top Key Companies for Automated Rapid Antimicrobial Susceptibility Testing Market: Merck KGaA, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Selux, Becton, Dickinson and Company, Liofilchem S.r.l., bioMérieux SA, Hi-Media Laboratories, Accelerate Diagnostics, Inc., Thermo Fisher Scientific, Q Linea, Bruker.
Global Automated Rapid Antimicrobial Susceptibility Testing Market Research Report: 2025-2032 Outlook with Market Insights, Industry and Competitive Analysis Included. Remarkable growth trajectory projected.
Global Automated Rapid Antimicrobial Susceptibility Testing Market Overview And Scope:
The Global Automated Rapid Antimicrobial Susceptibility Testing Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Automated Rapid Antimicrobial Susceptibility Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Automated Rapid Antimicrobial Susceptibility Testing Market Segmentation
By Type, Automated Rapid Antimicrobial Susceptibility Testing market has been segmented into:
Instruments
Consumables
By Application, Automated Rapid Antimicrobial Susceptibility Testing market has been segmented into:
Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations (CROs)
Regional Analysis of Automated Rapid Antimicrobial Susceptibility Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Automated Rapid Antimicrobial Susceptibility Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Automated Rapid Antimicrobial Susceptibility Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Automated Rapid Antimicrobial Susceptibility Testing market.
Top Key Companies Covered in Automated Rapid Antimicrobial Susceptibility Testing market are:
Merck KGaA
Roche Diagnostics Limited
Bio-Rad Laboratories
Inc.
Selux
Becton
Dickinson and Company
Liofilchem S.r.l.
bioMérieux SA
Hi-Media Laboratories
Accelerate Diagnostics
Inc.
Thermo Fisher Scientific
Q Linea
Bruker
Key Questions answered in the Automated Rapid Antimicrobial Susceptibility Testing Market Report:
1. What is the expected Automated Rapid Antimicrobial Susceptibility Testing Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Automated Rapid Antimicrobial Susceptibility Testing Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Automated Rapid Antimicrobial Susceptibility Testing Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Automated Rapid Antimicrobial Susceptibility Testing Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Automated Rapid Antimicrobial Susceptibility Testing companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Automated Rapid Antimicrobial Susceptibility Testing Markets?
7. How is the funding and investment landscape in the Automated Rapid Antimicrobial Susceptibility Testing Market?
8. Which are the leading consortiums and associations in the Automated Rapid Antimicrobial Susceptibility Testing Market, and what is their role in the market?
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Automated Rapid Antimicrobial Susceptibility Testing Market by Type
5.1 Automated Rapid Antimicrobial Susceptibility Testing Market Overview Snapshot and Growth Engine
5.2 Automated Rapid Antimicrobial Susceptibility Testing Market Overview
5.3 Instruments
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Instruments: Geographic Segmentation
5.4 Consumables
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Consumables: Geographic Segmentation
Chapter 6: Automated Rapid Antimicrobial Susceptibility Testing Market by Application
6.1 Automated Rapid Antimicrobial Susceptibility Testing Market Overview Snapshot and Growth Engine
6.2 Automated Rapid Antimicrobial Susceptibility Testing Market Overview
6.3 Hospitals and Diagnostic Centers
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals and Diagnostic Centers: Geographic Segmentation
6.4 Pharmaceutical and Biotechnology Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical and Biotechnology Companies: Geographic Segmentation
6.5 Research &Academic Institutes
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Research &Academic Institutes: Geographic Segmentation
6.6 Clinical Research Organizations (CROs)
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Clinical Research Organizations (CROs): Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Automated Rapid Antimicrobial Susceptibility Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Automated Rapid Antimicrobial Susceptibility Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Automated Rapid Antimicrobial Susceptibility Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MERCK KGAA
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ROCHE DIAGNOSTICS LIMITED
7.4 BIO-RAD LABORATORIES
7.5 INC.
7.6 SELUX
7.7 BECTON
7.8 DICKINSON AND COMPANY
7.9 LIOFILCHEM S.R.L.
7.10 BIOMÉRIEUX SA
7.11 HI-MEDIA LABORATORIES
7.12 ACCELERATE DIAGNOSTICS
7.13 INC.
7.14 THERMO FISHER SCIENTIFIC
7.15 Q LINEA
7.16 BRUKER
Chapter 8: Global Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Instruments
8.2.2 Consumables
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals and Diagnostic Centers
8.3.2 Pharmaceutical and Biotechnology Companies
8.3.3 Research &Academic Institutes
8.3.4 Clinical Research Organizations (CROs)
Chapter 9: North America Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Instruments
9.4.2 Consumables
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals and Diagnostic Centers
9.5.2 Pharmaceutical and Biotechnology Companies
9.5.3 Research &Academic Institutes
9.5.4 Clinical Research Organizations (CROs)
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Instruments
10.4.2 Consumables
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals and Diagnostic Centers
10.5.2 Pharmaceutical and Biotechnology Companies
10.5.3 Research &Academic Institutes
10.5.4 Clinical Research Organizations (CROs)
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Instruments
11.4.2 Consumables
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals and Diagnostic Centers
11.5.2 Pharmaceutical and Biotechnology Companies
11.5.3 Research &Academic Institutes
11.5.4 Clinical Research Organizations (CROs)
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Instruments
12.4.2 Consumables
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals and Diagnostic Centers
12.5.2 Pharmaceutical and Biotechnology Companies
12.5.3 Research &Academic Institutes
12.5.4 Clinical Research Organizations (CROs)
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Instruments
13.4.2 Consumables
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals and Diagnostic Centers
13.5.2 Pharmaceutical and Biotechnology Companies
13.5.3 Research &Academic Institutes
13.5.4 Clinical Research Organizations (CROs)
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Automated Rapid Antimicrobial Susceptibility Testing Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Instruments
14.4.2 Consumables
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals and Diagnostic Centers
14.5.2 Pharmaceutical and Biotechnology Companies
14.5.3 Research &Academic Institutes
14.5.4 Clinical Research Organizations (CROs)
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Automated Rapid Antimicrobial Susceptibility Testing Scope:
|
Report Data
|
Automated Rapid Antimicrobial Susceptibility Testing Market
|
|
Automated Rapid Antimicrobial Susceptibility Testing Market Size in 2025
|
USD XX million
|
|
Automated Rapid Antimicrobial Susceptibility Testing CAGR 2025 - 2032
|
XX%
|
|
Automated Rapid Antimicrobial Susceptibility Testing Base Year
|
2024
|
|
Automated Rapid Antimicrobial Susceptibility Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Merck KGaA, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Selux, Becton, Dickinson and Company, Liofilchem S.r.l., bioMérieux SA, Hi-Media Laboratories, Accelerate Diagnostics, Inc., Thermo Fisher Scientific, Q Linea, Bruker.
|
|
Key Segments
|
By Type
Instruments Consumables
By Applications
Hospitals and Diagnostic Centers Pharmaceutical and Biotechnology Companies Research &Academic Institutes Clinical Research Organizations (CROs)
|